Great Plains Bentonite + Herbal Detox Capsules 60 capsules, packaged in PETE amber…

Yerba Prima Inc recalled this product and the FDA reported the enforcement action on 25 June 2025 as Class II. The recall was initiated by the firm. Potential contamination with Pseudomonas aeruginosa.

The record

Every field below is published by the FDA in the openFDA food enforcement database. Check the FDA notice before acting on any recall: this page is a reading of the public record, not a substitute for it.

Product

Great Plains Bentonite + Herbal Detox Capsules 60 capsules, packaged in PETE amber bottle, white plastic cap and tamper proof seal. Case GTIN code:100 46352 00518 5. Retail package UPC code: 0 46352 00518 8. Yerba Prima, Inc. 740 Jefferson Ave Ashland, Oregon 97520 USA

Reason for recall

Potential contamination with Pseudomonas aeruginosa.

Recalling firm

Yerba Prima Inc

Firm location

Ashland, Oregon, United States

Classification

Class II

Status

Terminated

Recall number

H-0050-2025

Quantity

4985 bottles

Distribution

Distributed in AZ, CA, CO, CT, FL, GA, IA, IL, IN, KY, MD, MO, NC, NH, NV, NY, OH, PA, TX, VA, and WA.

Initiated

10 June 2025

Reported by FDA

25 June 2025

Terminated

5 September 2025

Firm notified by

Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Product codes

Lot # 05051, Expiration Date 02/2028. Lot code breaks down as follows: 050 = 3 digits pertaining to the day of the year 5 = last number of the year 2025 1 = number of batch records issued of the day

Reading this record

Five things about this record are not in the record itself, and each one changes how it should be read.

• Class II means the FDA judged a remote probability of serious harm, or a probability of temporary or medically reversible harm. The class is assigned by an agency health hazard evaluation under 21 CFR 7.41, not by the firm.
• The firm started this recall itself. Most FDA food recalls are voluntary, and a recall is a food safety plan working rather than failing. The circumstances in which the agency asks for one instead are set out in 21 CFR 7.45.
• This record is the only one the FDA opened for its recall event, so it covers a single product code.
• The recall ran for 3 months, from 10 June 2025 to termination on 5 September 2025. Termination means the agency judged that all reasonable effort had been made, under 21 CFR 7.55, and it says nothing about whether product remained in circulation.
• The distribution pattern names 20 states, and the FDA published the enforcement report 2 weeks after the firm began the recall.
• Recalls of a dietary supplement run a median of 15 months, so this one was shorter than usual for its category. Dietary supplements are regulated under their own good manufacturing practice rule, 21 CFR part 111, and they are the only food category where the dominant recall reason is an ingredient that was never declared because it is a pharmaceutical.

Named in the distribution pattern: California, Colorado, Connecticut, Florida, Georgia, Iowa, Illinois, Indiana, Kentucky, Maryland, Missouri, North Carolina, New Hampshire, Nevada, New York, Ohio, Pennsylvania, Texas, Virginia, Washington. Those pages count recalls by where the RECALLING FIRM sits, which is a different question from where this product went.

Filed under dietary supplements. A product can sit in more than one.

Other dietary supplements recalls

These are the closest records in the corpus: the same kind of food. Unlike the firm’s own records below, they come from different companies, which is what makes them a pattern rather than a history.

All 2025 recalls · All FDA food recall data